KOPRAN
|
The Current P/S Ratio of KOPRAN is 1.43.
Share Price | ₹190.4 | May 02,2025 |
Market Cap | ₹919.4 Cr | |
Sales-TTM | ₹643.3 Cr | TTM-Consolidated Results |
Price/Sales | 1.43x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KOPRAN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹919.4 Cr] as on May 02,2025
(/) Sales [ ₹643.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.43x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.43 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KOPRAN !
The chart below summarizes the trend in P/S Ratio of KOPRAN over the last five years.
Historical PS (Price/Sales) ratio chart of KOPRAN
PS Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.41x.
- KOPRAN 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 2.84x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 0.3x.
How does KOPRAN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KOPRAN | 643.3 | 1.43 | 919.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.50 | 438,778.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.84 | 161,949.0 |
CIPLA LTD | 26,981.2 | 4.57 | 123,222.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.75 | 110,205.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.16 | 98,707.7 |
MANKIND PHARMA LTD | 11,641.0 | 8.44 | 98,276.2 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.00 | 89,097.0 |
LUPIN LTD | 22,001.6 | 4.27 | 93,962.5 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.28 | 70,399.0 |
ABBOTT INDIA LTD | 6,243.2 | 10.47 | 65,347.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KOPRAN 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.43x |
Max industry PS | 17.84x |
Median industry PS | 4.57x |
Average industry PS | 6.79x |
You may also like the below Video Courses